Clinical trials
Type 2 Diabetes Patients clinical trials
Below are recruiting type 2 diabetes patients clinical trials, each written for real people, not researchers. We’re tracking 580 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06989723RecruitingPhase 4
Pioglitazone and empagliflozin for fatty liver in type 2 diabetes
This trial tests two diabetes pills (pioglitazone and empagliflozin) to see if they can reduce liver fat in people with type 2 diabetes and fatty liver disease. It may help if your diabetes is not well controlled and you have a fatty liver confirmed by a special ultrasound scan.
Seongnam-siAges 20 years+ - NCT07005362Recruiting
Fitbit and chatbot to help sedentary people with type 2 diabetes get active
This study tests if a Fitbit and a friendly AI chatbot can help you become more active. You'll get reminders and support to increase your daily movement safely.
Aurora, ColoradoAges 18–80 - NCT07005986Recruiting
Pyrophosphate as a biomarker for artery hardening in type 2 diabetes
This study looks at a substance in the blood called pyrophosphate that may help doctors detect a type of artery hardening (mediacalcinosis) in people with type 2 diabetes. It tests whether this substance can be a useful early warning sign.
Nice, FranceAges 40–70 - NCT07006272Recruiting
Closed-loop pump vs islet transplant for unstable type 1 diabetes
This study compares two advanced treatments for type 1 diabetes that is hard to control: a closed-loop insulin pump system (which automatically adjusts insulin) versus islet cell transplantation (which replaces the cells that make insulin). It is for people whose blood sugar stays very unstable despite using the best current therapies.
Lyon, Auvergne-Rhône-AlpesAges 18 years+ - NCT07026539RecruitingPhase 4
Finerenone for heart and kidney health in type 2 diabetes
This trial tests whether adding finerenone to your current diabetes medications can better protect your heart and kidneys. It is for people with type 2 diabetes who already take an SGLT2 inhibitor and an ACE inhibitor or ARB.
Aarhus NAges 18 years+ - NCT07038473Recruiting
Early detection of type 1 diabetes in relatives
This study screens brothers, sisters, and children of people with type 1 diabetes to find early signs of the disease before symptoms appear. The goal is to catch it early and offer monitoring or future prevention options.
Jeddah, Mecca RegionAges 1.5 years–18 years - NCT07042399Recruiting
Self-care study for type 2 diabetes
This study looks at how people with type 2 diabetes take care of themselves. It aims to learn more about their self-care habits so that doctors can better support them.
San Donato Milanese, MilanAges 18 years+ - NCT07059377RecruitingPhase 3
Semaglutide to help smokers with diabetes quit
This study tests if the diabetes drug semaglutide can help people with type 2 diabetes stop smoking more easily. Participants will get either semaglutide or a placebo to see if it improves quit rates.
Ottawa, OntarioAges 18 years+ - NCT07061301Recruiting
Leaving the hospital with insulin: a transition study
This study helps people with type 2 diabetes who just started using insulin in the hospital get ready to go home. It tests whether extra support and tools like a smart insulin cap and a continuous glucose monitor make the switch safer and easier.
Valencia, ValenciaAges 18–70 - NCT07066891Recruiting
AI insulin dose prediction for type 2 diabetes
This study tests an artificial intelligence system that helps predict the right insulin dose for people with type 2 diabetes who are using an insulin pump in the hospital. The goal is to make blood sugar control safer and more accurate.
Guangzhou, GuangdongAges 18–75 - NCT07069166Recruiting
Good bacteria mouth rinse for gum disease and diabetes
This study tests whether a mouth rinse containing helpful bacteria (called parabiotics) can improve gum health in people who have both gum disease and type 2 diabetes. It may offer a simple, non-drug way to manage inflammation.
Pavia, LombardyAges 18–70 - NCT07078565Recruiting
Tai Chi vs. Otago Exercises for Diabetic Nerve Pain
This study compares gentle Tai Chi exercises with a modified Otago exercise program to see which better helps with pain, balance, and movement in people with diabetic nerve pain. If you have had type 2 diabetes for at least 5 years and have chronic nerve pain, this trial may help you find relief and improve your mobility.
Lahore, Punjab ProvinceAges 40–80 - NCT07079189Recruiting
Digital lifestyle tool for type 2 diabetes
This trial tests a digital lifestyle tool combined with a smart chatbot to help people with type 2 diabetes improve their blood sugar control. It's a home-based program that gives personalized advice and support.
Malmö, Skåne CountyAges 35 years+ - NCT07083154RecruitingPhase 3
Testing a dual-action drug for diabetes and early memory loss
This study tests if a new type of diabetes drug that targets two natural hormones can help people with type 2 diabetes who also have early memory problems. If you have type 2 diabetes and mild cognitive impairment or mild dementia, this trial may offer a potential treatment option.
Changsha, HunanAges 50–75 - NCT07083336Recruiting
Diet study for type 2 diabetes with fatty liver disease
This trial tests a specific medical nutrition therapy diet to see if it can reduce liver fat and improve blood sugar control in people with type 2 diabetes and nonalcoholic fatty liver disease. It may help you manage both conditions with a dietary approach.
Yichang, HubeiAges 18 years+ - NCT07091162Recruiting
Genetic and CT screening for heart risk in diabetes
This trial uses your genetic risk score and a CT scan of your heart to see if changing how doctors manage your diabetes can lower your risk of heart problems. It is for adults with type 2 diabetes who haven't had heart disease symptoms.
Melbourne, VictoriaAges 40 years+ - NCT07093476RecruitingPhase 3
Adding empagliflozin to improve blood sugar control
This trial tests whether adding empagliflozin (a diabetes pill) to your current medicines (alogliptin and metformin) helps manage blood sugar better. It may be an option if your blood sugar is not well controlled with your current treatment.
SeoulAges 19 years+ - NCT07097818Recruiting
GLITTER Study: Better Blood Sugar Control in Type 1 Diabetes
This study tests a program to help people with type 1 diabetes improve their blood sugar control using continuous glucose monitors, insulin pumps, and education sessions. It includes remote monitoring and camp activities for some participants.
Beijing, Beijing MunicipalityAges 6 years+ - NCT07124923Recruiting
Diabetes support program for adults in primary care
This program tests a new continuous care approach to help people with type 2 diabetes manage their condition better. It is designed for adults who have had diabetes for at least a year and are not already seeing a specialist for diabetes care.
Amposta, TarragonaAges 18–90 - NCT07128186Recruiting
AI predicts memory decline in type 2 diabetes
This study uses an AI tool to predict memory problems in people with type 2 diabetes. It may help catch early signs of cognitive decline and guide future care.
Enshi, HubeiAges 40–75 - NCT07129915Recruiting
Can a smartphone nudge improve diabetes self-management?
This trial tests whether using a nudge-based digital tool (on your smartphone) helps people with type 2 diabetes make better decisions and manage their condition more effectively at home.
Xiamen, FujianAges 18 years+ - NCT07135531Recruiting
Blood sugar monitor study for uninsured patients with type 2 diabetes
This study tests if using a continuous glucose monitor (a small sensor that checks blood sugar without finger pricks) helps people with type 2 diabetes who are on insulin and have trouble accessing care. It's for patients in the New Orleans area with Medicaid, free care, or no insurance.
New Orleans, LouisianaAges 18–75 - NCT07144696Recruiting
Study to improve metabolic health in type 1 diabetes
This study offers a structured education course and regular checkups to help adults with type 1 diabetes better manage their blood sugar and overall health. Participants will learn about their condition and receive support to improve metabolic indicators.
BeijingAges 18 years+ - NCT07149610Recruiting
Connected care for type 2 diabetes self-management
This study tests a connected care program to help people with type 2 diabetes manage their condition better using a smartphone. It may help you if your blood sugar is not well controlled and you live in the Marche region of Italy.
Ancona, AnconaAges 18 years+
Hear when a new Type 2 Diabetes Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 2 diabetes patients?
- Yes. Clin2 currently lists 580 recruiting type 2 diabetes patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 2 diabetes patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 2 diabetes patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.